Literature DB >> 21659758

Epigenetic mechanisms.

Louisa M Villeneuve, Rama Natarajan.   

Abstract

The incidence of diabetes and related complications like nephropathy is growing rapidly and has become a major health care issue. Changes in the environment and nutritional habits have been implicated as major players. Furthermore, it is becoming increasingly clear that epigenetic factors may modulate the connections between genes and the environment. While diabetes in itself is treatable to a large extent, it is still associated with significantly increased risk for complications including chronic kidney and cardiovascular diseases. Current treatments have added preventative approaches so as to avoid future diabetic complications. Unfortunately, diabetic patients are often plagued with the continued development of various complications even after achieving glucose control. This has been suggested to be attributable to a mysterious phenomenon termed 'metabolic memory' of the prior glycemic state. Recent studies have suggested that epigenetic changes to chromatin can affect gene expression in response to various stimuli, and changes in key biochemical pathways and epigenetic histone and DNA methylation patterns in chromatin have been observed in a diabetic milieu. These accumulating data suggest that metabolic or hyperglycemic memory may be due to epigenetic changes in specific target tissues altering gene expression without changing the genetic code itself. While the genetics of diabetes has long been the focus of scientific research, much less is known about the role of epigenetics and the related molecular pathways that might affect the development of diabetes and the associated complications. Further studies of epigenetic mechanisms are therefore timely and could provide valuable new insights into the pathology of diabetic complications and also uncover much needed new therapeutic targets.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21659758      PMCID: PMC6699750          DOI: 10.1159/000324944

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  8 in total

Review 1.  Proteostasis in endoplasmic reticulum--new mechanisms in kidney disease.

Authors:  Reiko Inagi; Yu Ishimoto; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2014-04-22       Impact factor: 28.314

Review 2.  Epigenetics and the transition from acute to chronic pain.

Authors:  Thomas Buchheit; Thomas Van de Ven; Andrew Shaw
Journal:  Pain Med       Date:  2012-09-14       Impact factor: 3.750

3.  Integrative Biology of Diabetic Kidney Disease.

Authors:  Jennifer L Harder; Jeffrey B Hodgin; Matthias Kretzler
Journal:  Kidney Dis (Basel)       Date:  2015-09-23

Review 4.  Epigenetics in the development, modification, and prevention of cardiovascular disease.

Authors:  Thomas F Whayne
Journal:  Mol Biol Rep       Date:  2014-09-10       Impact factor: 2.316

Review 5.  Vascular memory: can we broaden the concept of the metabolic memory?

Authors:  György Jermendy
Journal:  Cardiovasc Diabetol       Date:  2012-04-30       Impact factor: 9.951

Review 6.  Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis.

Authors:  Jing Sun; Yangwei Wang; Wenpeng Cui; Yan Lou; Guangdong Sun; Dongmei Zhang; Lining Miao
Journal:  J Diabetes Res       Date:  2017-06-13       Impact factor: 4.011

Review 7.  Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease.

Authors:  Julio M Martinez-Moreno; Miguel Fontecha-Barriuso; Diego Martin-Sanchez; Juan Guerrero-Mauvecin; Elena Goma-Garces; Beatriz Fernandez-Fernandez; Sol Carriazo; Maria D Sanchez-Niño; Adrian M Ramos; Marta Ruiz-Ortega; Alberto Ortiz; Ana B Sanz
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

8.  Comprehensive analyses reveal the role of histone deacetylase genes in prognosis and immune response in low-grade glioma.

Authors:  Lin Shen; Yanyan Li; Na Li; Liangfang Shen; Zhanzhan Li
Journal:  PLoS One       Date:  2022-10-13       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.